Fig. 4From: Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cellsEffects of the commercial GPR55 antagonist ML193 (a) and agonist O-1602 alone and in combination with ML 193 and KIT17 (b) on PGE2 release in LPS-stimulated primary microglial cells compared to KIT 17 aloneBack to article page